Etienne DePlaen

Person

Brussels, BE

People

Patents Grantslast 30 patents

Information Patent Grant
Tumour rejection antigens
- Patent number 8,519,109
- Issue date Aug 27, 2013
- Ludwig Institute for Cancer Research Ltd.
- Lan-Qing Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
- Patent number 7,923,534
- Issue date Apr 12, 2011
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor rejection antigens
- Patent number 7,547,439
- Issue date Jun 16, 2009
- Ludwig Institute for Cancer Research
- Lan-Qing Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...
- Patent number RE40089
- Issue date Feb 19, 2008
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- 536 - Organic compounds
Information Patent Grant
METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORM...
- Patent number 6,669,946
- Issue date Dec 30, 2003
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating cancer by administering MAGE-derived peptides
- Patent number 6,488,932
- Issue date Dec 3, 2002
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated molecules which complex with HLA-Cw*16 molecules, and uses...
- Patent number 6,429,287
- Issue date Aug 6, 2002
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for screening for cancer using binders for MAGE related pept...
- Patent number 6,379,901
- Issue date Apr 30, 2002
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated peptides which comply with HLA-CW16 molecules and uses
- Patent number 6,323,028
- Issue date Nov 27, 2001
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of identifying individuals suffering from a cellular abnorma...
- Patent number 6,284,476
- Issue date Sep 4, 2001
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated peptides which complex with HLA-Cw16 and uses thereof
- Patent number 6,265,215
- Issue date Jul 24, 2001
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for determining cancer by determining expression of MAGE-10
- Patent number 6,221,593
- Issue date Apr 24, 2001
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nonapeptides presented by HLA molecules, and uses thereof
- Patent number 6,222,012
- Issue date Apr 24, 2001
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating subjects with disorders characterized by expre...
- Patent number 6,201,111
- Issue date Mar 13, 2001
- Ludwig Institute for Cancer Research
- Vincent Brichard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nonapeptides which bind to HLA molecules and provoke lysis...
- Patent number 6,034,214
- Issue date Mar 7, 2000
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Precursor processed to at least one tumor rejection antigen present...
- Patent number 6,001,975
- Issue date Dec 14, 1999
- Ludwig Institute for Cancer Research
- Vincent Brichard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated peptides which complex with HLA-Cw*16 molecules, and uses...
- Patent number 5,928,938
- Issue date Jul 27, 1999
- Ludwig Institute for Cancer Research
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor rejection antigen precursors, tumor rejection antigens and us...
- Patent number 5,925,729
- Issue date Jul 20, 1999
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid sequence coding for a tumor rejection antigen...
- Patent number 5,856,091
- Issue date Jan 5, 1999
- Ludwig Institute for Cancer Research
- Vincent Brichard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor rejection antigen precursor processed to at least one tumor r...
- Patent number 5,854,203
- Issue date Dec 29, 1998
- Ludwig Institute for Cancer Research
- Vincent Brichard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated tyrosinase derived peptides and uses thereof
- Patent number 5,843,688
- Issue date Dec 1, 1998
- Ludwig Institute for Cancer Research
- Thomas Wolfel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for determining disorders by assaying for a non-tyrosinase,...
- Patent number 5,837,476
- Issue date Nov 17, 1998
- Ludwig Institute
- Vincent Brichard
- G01 - MEASURING TESTING
Information Patent Grant
Method for determining lung adenocarcinomas by assaying for one or...
- Patent number 5,763,155
- Issue date Jun 9, 1998
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for determining lung adenocarcinomas by assaying for one or...
- Patent number 5,763,165
- Issue date Jun 9, 1998
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for identifying individuals suffering from a cellular abnorm...
- Patent number 5,747,271
- Issue date May 5, 1998
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated cytolytic T cells specific for complexes of MAGE related p...
- Patent number 5,695,994
- Issue date Dec 9, 1997
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid sequence coding for a tumor rejection antigen...
- Patent number 5,620,886
- Issue date Apr 15, 1997
- Ludwig Institute for Cancer Research
- Vincent Brichard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules useful in determining expression of...
- Patent number 5,612,201
- Issue date Mar 18, 1997
- Ludwig Institute for Cancer Research
- Etienne De Plaen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated, tyrosinase derived peptides and uses thereof
- Patent number 5,530,096
- Issue date Jun 25, 1996
- Ludwig Institute for Cancer Research
- Thomas Wolfel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for determining head and neck squamous cell carcinomas, pros...
- Patent number 5,512,437
- Issue date Apr 30, 1996
- Ludwig Institute for Cancer Research
- Beatrice Gaugler
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS
- Publication number 20110159017
- Publication date Jun 30, 2011
- Ludwig Institute for Cancer Research Ltd.
- Benoit Van Den Eynde
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TUMOUR REJECTION ANTIGENS
- Publication number 20090209034
- Publication date Aug 20, 2009
- Ludwig Institute for Cancer Research Ltd.
- Lan-Qing Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isolated molecules which complex with HLA-Cw*16 molecules, and uses...
- Publication number 20030166837
- Publication date Sep 4, 2003
- Pierre van der Bruggen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Etienne DePlaen

Person

Patents Grantslast 30 patents

Tumour rejection antigens

Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3

Tumor rejection antigens

Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...

METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORM...

Method for treating cancer by administering MAGE-derived peptides

Isolated molecules which complex with HLA-Cw*16 molecules, and uses...

Method for screening for cancer using binders for MAGE related pept...

Isolated peptides which comply with HLA-CW16 molecules and uses

Method of identifying individuals suffering from a cellular abnorma...

Isolated peptides which complex with HLA-Cw16 and uses thereof

Method for determining cancer by determining expression of MAGE-10

Isolated nonapeptides presented by HLA molecules, and uses thereof

Methods for treating subjects with disorders characterized by expre...

Isolated nonapeptides which bind to HLA molecules and provoke lysis...

Precursor processed to at least one tumor rejection antigen present...

Isolated peptides which complex with HLA-Cw*16 molecules, and uses...

Tumor rejection antigen precursors, tumor rejection antigens and us...

Isolated nucleic acid sequence coding for a tumor rejection antigen...

Tumor rejection antigen precursor processed to at least one tumor r...

Isolated tyrosinase derived peptides and uses thereof

Methods for determining disorders by assaying for a non-tyrosinase,...

Method for determining lung adenocarcinomas by assaying for one or...

Method for determining lung adenocarcinomas by assaying for one or...

Method for identifying individuals suffering from a cellular abnorm...

Isolated cytolytic T cells specific for complexes of MAGE related p...

Isolated nucleic acid sequence coding for a tumor rejection antigen...

Isolated nucleic acid molecules useful in determining expression of...

Isolated, tyrosinase derived peptides and uses thereof

Method for determining head and neck squamous cell carcinomas, pros...

Patents Applicationslast 30 patents

TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS

TUMOUR REJECTION ANTIGENS

Isolated molecules which complex with HLA-Cw*16 molecules, and uses...